Stockholder's Equity - Series A & B Warrants (Details) - USD ($)	9 Months Ended		12 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Dec. 31, 2020	Aug. 31, 2022	Aug. 04, 2022	Aug. 03, 2022	Nov. 30, 2021	Mar. 04, 2021	Nov. 19, 2020	May 22, 2020
Class of Stock [Line Items]
Issued	144,866
TardiMed
Class of Stock [Line Items]
Issued	181,083						36,196
Exercised	(36,217)
Outstanding and exercisable, end of period	144,866
Weighted Average Exercise Price Rollforward
Weighted Average Exercise Price	$ 0.005
Weighted Average Price, Issued	0.005
Weighted Average Price, Exercised	$ 0.005
Weighted Average Remaining Contractual Term (Years) rollforward
Aggregate Intrinsic Value	$ 868,472
Aggregate Intrinsic Value, Issued	1,085,590
Aggregate Intrinsic Value, Exercised	$ (217,118)
Series A Warrants
Class of Stock [Line Items]
Outstanding, beginning of period	334,036
Issued	334,036									403,564
Exercised		(69,528)
Outstanding and exercisable, end of period	334,036		334,036
Weighted Average Exercise Price Rollforward
Weighted Average Exercise Price	$ 58.00		$ 58.00
Weighted Average Remaining Contractual Term (Years) rollforward
Weighted average remaining contractual term ( in years)	2 years 8 months 12 days		3 years 4 months 24 days
Issuance of common stock in warrant exchange (in shares)		41,192
Series B Warrants
Class of Stock [Line Items]
Outstanding, beginning of period		149,481	149,481
Issued									455,336
Exercised		(149,481)
Outstanding and exercisable, end of period				149,481
Weighted Average Exercise Price Rollforward
Weighted Average Exercise Price				$ 0.05
Weighted Average Price, Exercised		$ 0.05
Weighted Average Remaining Contractual Term (Years) rollforward
Aggregate Intrinsic Value				$ 7,474
Issuance of common stock in warrant exchange (in shares)		149,353
Bridge warrants
Class of Stock [Line Items]
Outstanding, beginning of period	8,275
Issued											8,275
Outstanding and exercisable, end of period	8,275		8,275
Weighted Average Exercise Price Rollforward
Weighted Average Exercise Price	$ 1.00		$ 1.00
Weighted Average Remaining Contractual Term (Years) rollforward
Weighted average remaining contractual term ( in years)	2 years 7 months 6 days		3 years 4 months 24 days
Aggregate Intrinsic Value	$ 41,375		$ 28,963
November 2021
Class of Stock [Line Items]
Outstanding, beginning of period	539,063
Outstanding and exercisable, end of period	539,063		539,063
Weighted Average Exercise Price Rollforward
Weighted Average Exercise Price	$ 35.00		$ 35.00
Weighted Average Remaining Contractual Term (Years) rollforward
Weighted average remaining contractual term ( in years)	4 years 1 month 6 days		4 years 9 months 18 days
Aggregate Intrinsic Value	$ 7,101,563		$ 7,101,563					$ 7,100,000
Number of warrants exercised	0		0
August 2022 Common Stock Warrants
Class of Stock [Line Items]
Issued	1,333,333					1,333,333
Exercised	(24,000)
Outstanding and exercisable, end of period	1,309,333
Weighted Average Exercise Price Rollforward
Weighted Average Exercise Price	$ 6.00
Weighted Average Price, Issued	6.00
Weighted Average Price, Exercised	$ 6.00
Weighted Average Remaining Contractual Term (Years) rollforward
Weighted average remaining contractual term ( in years)	4 years 10 months 24 days
Aggregate Intrinsic Value	$ 4,844,533				$ 4,900,000
Aggregate Intrinsic Value, Issued	4,933,333
Aggregate Intrinsic Value, Exercised	$ (88,800)